Cargando…
Inhibiting TRF1 upstream signaling pathways to target telomeres in cancer cells
In the context of tumorigenesis, telomere shortening is associated with apparent antagonistic outcomes: On one side, it favors cancer initiation through mechanisms involving genome instability, while on the other side, it prevents cancer progression, due to the activation of the DNA damage response...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6609909/ https://www.ncbi.nlm.nih.gov/pubmed/31273935 http://dx.doi.org/10.15252/emmm.201910845 |